Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Pila Pharma AB (publ)

PILA.ST

HealthcareSTOSE

SEK 1.56

+SEK 0.06 (+4.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

PILA.ST

1Y+0.06 (+4.00%)

Candles, volume, SMA 20, and SMA 50

O 1.54H 1.575L 1.43C 1.56Date Jun 10

PILA.ST

SMA 20 SMA 50 Vol 18.83K

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Based in Sweden, PILA PHARMA AB (publ) is a pharmaceutical firm actively engaged in clinical development. The company's principal drug, XEN-D0501, is a TRPV1 antagonist which has successfully completed two phase 2a clinical studies aimed at treating type 2 diabetes. PILA PHARMA AB (publ) was founded in 2014 and maintains its headquarters in Malmö, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$71.26M

Volume?18.83K

Avg Volume?112.38K

52w RangeSEK 1.024 - SEK 3.93

Beta?-0.31

Price Performance

No historical price data is available for this symbol yet.

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide